Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-08-05
2009-11-17
Davis, Zinna N (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S256000, C514S357000, C514S396000, C514S406000, C514S438000, C514S461000, C544S224000, C544S242000, C544S336000, C546S334000, C548S377100, C549S075000, C549S429000
Reexamination Certificate
active
07618969
ABSTRACT:
Compounds of formula (I) or a pharmaceutically acceptable salt, solvate or prodrug thereof, are disclosed:wherein R1is C1-6alkyl, haloC1-6alkyl, C2-6alkenyl, amino, monoC1-4alkylamino or diC1-4alkylamino; R2and R3, which may be the same or different, are hydrogen, halogen, C1-6alkyl, haloC1-6alkyl, C1-4alkoxy, haloC1-4alkoxy, cyano, amino, monoC1-4alkylamino or diC1-4alkylamino; each R4, which may be the same or different, is C1-6alkyl, halogen, C1-6alkyl, haloC1-6alkyl, C1-4alkoxy, haloC1-4alkoxy, cyano, nitro, amino, monoC1-4alkylamino or diC1-4alkylamino; p is 0, 1 or 2; n is 1 or 2; R5and R6, which may be the same or different, are hydrogen, halogen, C1-6alkyl, haloC1-6alkyl, C1-4alkoxy, haloC1-4alkoxy, cyano, amino, monoC1-4alkylamino or diC1-4alkylamino; and Het is thienyl, pyridyl, pyrimidinyl, pyridazinyl, pyrimidinyl, pyrazinyl, imidazolyl, pyrazolyl, pyrrolyl, quinolyl, thiazolyl or furyl, each of which may be substituted by one or more groups independently selected from the list consisting of C1-6alkyl, C1-6alkoxy, acetyl, halogen, haloC1-6alkyl, cyano, nitro, amino, monoC1-4alkylamino and diC1-4alkylamino. Methods of preparation of the compounds, and uses thereof in medicine, for example treatment of schizophrenia, are also disclosed.
REFERENCES:
patent: 0 980 864 (2000-02-01), None
patent: WO 00/66546 (2000-11-01), None
patent: WO 01/96289 (2001-12-01), None
Bradley Daniel Marcus
Thewlis Kevin Michael
Ward Simon Edward
Davis Zinna N
Gimmi Edward R.
Glaxo Group Limited
Kanagy James M.
Kinzig Charles M.
LandOfFree
Compounds which potentiate glutamate receptor and uses... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compounds which potentiate glutamate receptor and uses..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds which potentiate glutamate receptor and uses... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4070523